Skip to content
NEW: CREATE AN AI-ASSISTED TENDER IN 2 MINUTES — TRY IT FREE
Back to search
Arvin BioHealth – Fertigung

Development and production of lateral flow rapid tests, ELISA kits and diagnostic reagents for human and veterinary diagnostics.

Arvin BioHealth Logo

Arvin BioHealth (Arvin Zist Salamat)

IranNew on Amplifa

2015Founded (1395 in the Iranian calendar)
Knowledge-based companySubsidiary of the Arvin Pazhoohan Noor (APN) Holding
EN ISO 13485:2016Quality management system for medical devices
2023First production of pet rapid tests in Iran

About Arvin BioHealth

Arvin BioHealth (Persian: Arvin Zist Salamat) is a knowledge-based company founded in 2015 (1395 in the Iranian calendar) as a subsidiary of the Arvin Pazhoohan Noor (APN) Holding by university lecturers and research centers. The company researches, develops, manufactures and distributes in vitro diagnostics, including lateral flow rapid tests (including SARS-CoV-2 antigen, IgG/IgM and neutralizing antibody tests, pregnancy tests, drug tests, cardiac troponin I, FOB), ELISA kits and diagnostic reagents. In addition, raw materials for the vaccine industry and biotechnology products are manufactured. Production is carried out in accordance with EN ISO 13485:2016 with cleanrooms and modern production infrastructure. In 2023, as the first manufacturer in Iran, production of rapid tests for pet diseases was launched with approval from the Veterinary Organization. The products are used in hospitals, clinical laboratories, medical practices, veterinary clinics as well as for home use for screening, prognosis, diagnosis and therapy monitoring purposes. The company's own R&D team develops custom assays and manufactures prototypes according to customers' ideas.

Site
Iran
Processes
Manufacture of rapid diagnostic tests (immunochromatography/lateral flow), Manufacture of ELISA kits, Manufacture of diagnostic reagents, Manufacture of raw materials for the vaccine industry and biotechnology products, R&D: development of lateral flow and ELISA assays, prototype development, Production in accordance with EN ISO 13485:2016 with cleanrooms, Research & Development (R&D, lateral flow and ELISA assays), Production of rapid diagnostic kits
Materials
Immunochromatography / Lateral Flow, ELISA (Enzyme-linked Immunosorbent Assay), Diagnostic reagents, Raw materials for the vaccine industry and biotechnology
Certificates
EN ISO 13485:2016
Founded
2015 (1395
Industries
Medical technology/IVD, Veterinary diagnostics, Vaccine industry, Biotechnology, Agriculture, Medical technology/IVD (in vitro diagnostics)
  1. 01

    Research & Development (Lateral Flow, ELISA, prototypes)

  2. 02

    Raw material production

  3. 03

    Manufacture of rapid diagnostic kits and ELISA kits

  4. 04

    Reagent production

  5. 05

    Quality control in accordance with EN ISO 13485:2016

  6. 06

    Sales and distribution

Product Areas and Processes

LFA

Immunochromatography / Lateral Flow

Rapid tests for antigen, antibody and drug detection in serum, plasma, whole blood and urine.

ELISA

ELISA (Enzyme-linked Immunosorbent Assay)

Laboratory diagnostic kits for quantitative detection in clinical laboratories.

REAG

Diagnostic reagents

Reagents for clinical diagnostics.

RAW

Raw materials for the vaccine industry and biotechnology

Production of starting materials for vaccines and biotechnology products.

Location

Iran

DE

Manufacturing, R&D and sales

Materials
Lateral Flow, ELISA, reagents
  • Production machines for IVD products
  • Cleanrooms

Products

SARS-CoV-2 Antigen Rapid Test Kit
SARS-CoV-2 Antigen Rapid Test KitLateral Flow · Medical technology/IVD
SARS-CoV-2 rapid test (corona test)
SARS-CoV-2 rapid test (corona test)Lateral Flow · Medical technology/IVD
Influenza rapid test
Influenza rapid testLateral Flow · Medical technology/IVD
Rapid test for pet diseases
Rapid test for pet diseasesImmunochromatography · Veterinary diagnostics
Rapid test kits for human/veterinary diagnostics
Rapid test kits for human/veterinary diagnosticsLateral Flow · IVD/Veterinary diagnostics

Inside the production

Arvin BioHealth company location
Arvin BioHealth company location
Arvin Pazhoohan Noor (APN) Holding
Arvin Pazhoohan Noor (APN) Holding
Product presentation (video poster)
Product presentation (video poster)
Presence of the knowledge-based company
Presence of the knowledge-based company
Arvin Zist Salamat
Arvin Zist Salamat

Industries

Medical technology/IVDVeterinary diagnosticsVaccine industryBiotechnologyAgricultureMedical technology/IVD (in vitro diagnostics)

Processes & technical limits

ProcessesToleranceMax. partWeightLot sizeMaterials
Manufacture of rapid diagnostic tests (immunochromatography/lateral flow)Testing–––––
Manufacture of ELISA kitsTesting–––––
Manufacture of diagnostic reagentsTesting–––––
Manufacture of raw materials for the vaccine industry and biotechnology productsEngineering–––––
R&D: development of lateral flow and ELISA assays, prototype developmentEngineering–––––
Production in accordance with EN ISO 13485:2016 with cleanroomsTesting–––––

2 Anlagen & Maschinen

MachineManufacturer / modelQuantityWorking areaYear builtSite
Production machines for IVD products (not specified)––––Iran
Cleanrooms––––Iran

Additional services

Research & Development (R&D, lateral flow and ELISA assays)Production of rapid diagnostic kitsELISA kitsDiagnostic reagentsProduction of raw materials for the vaccine industry and biotechnologyCustomized development (prototype development according to customers' ideas)

Quality

Production is carried out in accordance with the EN ISO 13485:2016 quality management system for medical devices with cleanrooms, experienced technical personnel and its own quality assurance (headed by Dr. Ahmadi).

EvidenceIran
EN ISO 13485:2016

History

  1. 2015

    Founded as a knowledge-based company under the Arvin Pazhoohan Noor (APN) Holding by university members and research centers; recognized by governmental science and innovation organizations.

  2. 2020

    Development and production of SARS-CoV-2 rapid tests (IgG/IgM, neutralizing antibody, antigen) for rapid diagnosis during the corona epidemic in Iran; presented in the TV program 'Nowavaran' on Iranian state television.

  3. 2023

    First production of rapid tests for pet diseases in Iran with approval from the Veterinary Organization.

Personalised demo

Ready to see Amplifa Marketplace in action?

From a structured request to the right manufacturing partner: AI-assisted matching, verified suppliers and transparent metrics — in one place for industrial companies across the DACH region.

Request a demo